Director, Global Asset Lead - Late-Phase Oncology

Women In Bio

Collegeville (PA)

On-site

USD 190,000 - 316,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Annual bonus
Long term incentive program
Health care and other insurance
Retirement benefits
Paid holidays and vacation

Job summary

GSK is seeking a Clinical Operations Asset Lead (COAL) for Late Phase Lung Oncology. You will own end-to-end operational delivery of assets across lifecycle, shaping development plans, leading cross-functional teams, and ensuring risk-managed execution with quality by design.

Experience in BLA readiness and global programs is essential. The role requires a strong background in hematology/oncology, strategic leadership, and the ability to coordinate across clinical operations and regulatory

Qualifications

  • Bachelor's degree in life sciences, healthcare, business or related field, or equivalent experience.
  • Minimum 10 years of pharmaceutical R&D or related industry experience.
  • At least 3 years as COAL (or similar) in lung cancer indications.
  • 5+ years with global, complex programs with multiple studies.
  • Experience with preparing for BLA filing and BLA inspection readiness.
  • Deep therapeutic area expertise in lung treatment landscape and competitive env.

Responsibilities

  • Own the clinical operational strategy and end-to-end delivery of the asset across its lifecycle.
  • Shape the Clinical Development Plan and Integrated Evidence Plan.
  • Lead asset-level planning and scenario modelling balancing timelines, cost, resources, quality and risk.
  • Define and oversee asset resourcing strategy including insourcing/outsourcing and vendor oversight.
  • Provide strategic leadership across Study Delivery Teams and escalation point for issues.
  • Drive asset-level risk management and inspection readiness; ensure Quality by Design.
  • Lead operational strategies across countries, patient engagement and study execution.
  • Ensure robust governance including budget forecasting and regulatory contributions.

Skills

Analytical Thinking
Clinical Data Interpretation
Clinical Data Review
Clinical Development
Clinical Trial Designs
Clinical Trials Monitoring
Digital Fluency
Drug Regulatory Affairs
Executive Presence
Hematology and Oncology
Learning Agility
Matrix Leadership
Real World Evidence (RWE)
Scientific Presentations

Education

Bachelor's degree in life sciences
Advanced degree (Master's, PhD, PharmD, MD)

Job description

GSK is seeking a Clinical Operations Asset Lead (COAL) for Late Phase Lung Oncology. You will own end-to-end operational delivery of assets across lifecycle, shaping development plans, leading cross-functional teams, and ensuring risk-managed execution with quality by design.

Experience in BLA readiness and global programs is essential. The role requires a strong background in hematology/oncology, strategic leadership, and the ability to coordinate across clinical operations and regulatory

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Clinical Operations Asset Lead, Late-Phase Lung Oncology
Clinical Operations Asset Lead, Late-Phase Lung Oncology

GlaxoSmithKline plc • Upper Providence

On-site
USD 190,000 - 316,000
Global COAL: Late-Phase Lung Oncology Asset Lead
Global COAL: Late-Phase Lung Oncology Asset Lead

GlaxoSmithKline • Rockville (MD)

On-site
USD 190,000 - 316,000
Annual bonus
Share-based long term incentive
Health care and other insurance
Senior Clinical Operations Asset Lead — Lung Oncology
Senior Clinical Operations Asset Lead — Lung Oncology

GlaxoSmithKline • Philadelphia

On-site
USD 190,000 - 316,000
Health benefits
Retirement benefits
Paid holidays
+2
Senior COAL - Late-Phase Lung Oncology Lead
Senior COAL - Late-Phase Lung Oncology Lead

GlaxoSmithKline • Waltham (MA)

On-site
USD 190,000 - 316,000
Health care
Retirement benefits
Paid holidays
+2
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GlaxoSmithKline plc • Upper Providence

On-site
USD 190,000 - 316,000
Global Oncology Program Lead
Global Oncology Program Lead

GlaxoSmithKline • Waltham (MA)

On-site
USD 139,000 - 232,000
Health insurance
Retirement benefits
Paid holidays
+3
Executive Medical Director, Oncology CD Lead
Executive Medical Director, Oncology CD Lead

GlaxoSmithKline • Upper Providence

Hybrid
USD 242,000 - 404,000
Health care benefits
Annual bonus
Long-term incentive program
Chief Oncology Clinical Strategy Lead
Chief Oncology Clinical Strategy Lead

GSK • Upper Providence

Hybrid
USD 242,000 - 404,000
Annual bonus
Health care and insurance benefits
Retirement benefits
+2
Associate Director, Global Oncology Programs
Associate Director, Global Oncology Programs

GlaxoSmithKline • Upper Providence

On-site
USD 139,000 - 232,000
Annual bonus
Health care benefits
Retirement benefits
+2
Executive Oncology Clinical Development Lead
Executive Oncology Clinical Development Lead

GlaxoSmithKline • Waltham (MA)

Hybrid
USD 242,000 - 404,000
Annual bonus
Long-term incentive program
Health care benefits (employee & a
+2